Calcium & Phosphate Metabolism
INDIAN DENTAL ACADEMY
Leader in continuing Dental Education
Contents
Introduction
Sources
Requirements
Distribution
Absorption
Excretion
Functions
Regulation of calcium & phosphate metabolism
Associated disorders
Periodontal considerations
Sources of calcium & phophorus
Calcium:
Milk & milk products
Eggs
Meat
Leafy vegetables
Fruits
Nuts
Ragi
Phosphorus
Same as calcium
More in cereals & pulses
RDA
Calcium:
Adult 500-800 mg/day
In pregnancy 1500 mg/day
Lactating mothers 2000 mg/day
New born and Infants 360 mg/day
Children 800 mg/day
Phosphorus
Adults 500-800 mg/day
Pregnant/lactating 1200 mg/day
Adolscents 1200 mg/day
Infants 240 mg/day
Distribution of Calcium & phosphorus
Calcium:
Total body calcium : 1100-1200 gms Plasma Ca levels: 9-11 mg/dl
99% Bone & teeth
1%: 0.9% soft tissue, 0.1% ECF
Daily Calcium Balance
Phosphorus:
Total body phosphorus: 500-800 mg
85% bone, 15% Liver, pancreas, brain
Plasma phosphate: 2.5-4.5 mg/dl
Organic form: 0.5-1 mg/dl
Inorganic form: 3-4 mg/dl in adults
5-6 mg/dl in children
Absorption of calcium & phosphate
Calcium : 40% absorption
Factors influencing absorption:
1. Influencing mucosal cells
2. Influencing solubility of calcium
Factors influencing mucosal cells:
1. Vit D
2. Body calcium Stores
3. Pregnancy & growth
4. Growth hormone
Factors influencing availability of Ca in gut
1. pH
2. Amount of dietary calcium and phosphorus
3. Phytic acid & phytates
4. Oxalates
5. Fat
6. Proteins
7. Carbohydrates
8. Bile salts
Absorption of phosphate:
Factors increasing Ca absorption also increase phosphate absorption
Occurs in Duodenum
Small Intestine
Calcium absorption
Factors favoring:
1. PTH
2. Vit D
3. High protein diet
4. Acidic pH
5. Negative Cal balance
6. Pregnancy, lactation, growth
7. Carbohydrates
Factors negating:
1. Oxalates, phytates
2. Excess lipid
3. Excess phosphate
4. Corticosteroids
5. Thyroid hormone
6. Alkaline pH
7. High body stores
Phosphate absorption
Factors favouring:
1. Low calcium diet
2. PTH
3. Vit D
4. Growth hormone
Factors negating:
1. High Ca diet
2. Vit D deficiency
3. Antacids
Excretion of calcium & phosphate:
1. Faeces: most of unabsorbed calcium constitutes fecal calcium
2. Urine: under full body control
maintenance of homeostasis
Ca in urine decreases with increased phosphate intake
High phosphate diet serum Pi PTH→ ↑ → ↑
↓
reabsorption of Ca from kidney
Plasma phosphate threshold value
Urine phosphate proportional to plasma phosphate
Threshold value:- 2-2.4 mg/dl
Functions of calcium & phosphorus
Calcium:
1. Major component of skeleton, bone & teeth
2. Cell membrane stabilization
3. Maintenance of nerve excitability & muscle contraction
4. Skeletal & smooth muscle contraction
5. Neurotransmitter release
6. Activation of enzymes
7. Secretion of hormones
8. Blood coagulation
Functions of phosphorus:
1. Formn of bone, teeth- hydroxyapatite
2. Essential components: Nucleoproteins
phospholipids
power molecules: ATP, NADPH, GTP
3. Reguln of blood pH & urine pH
4. Intermediate in fat & carbohydrate metabolism
5. Deamination & transamination of amino acids
6. Regulation of glycolysis
Regulation of Calcium, Phosphate Metabolism
• Organ systems that play an import role in Ca2+
metabolism
– Skeleton
– GI tract
– Kidney
• Hormones
– Parathyroid hormone (PTH)
– Calcitonin (CT)
– Vitamin D (1,25 dihydroxycholecalciferol)
– Parathyroid hormone related protein (PTHrP)
Overview of Calcium-Phosphate Regulation
Parathyroid Hormone
secreted by the parathyroid glands
polypeptide containing 84 amino acids.
Overall effect : increase Ca conc in plasma
Lowers plasma phosphate concentration
Regulation of PTH Secretion:
Extracellular Ca ( Ca conc <7 mg/dl)
Ca2+ also regulates transcription
High levels of Vit D inhibit transcription
Calcium Sensing Receptor (CaSR)
•Parathyroid chief cells contain a Ca2+
sensing receptor (CaSR)
•There are two paradoxes
-The receptor responds to decreasing concentrations of agonist
-Low extracellular Ca2+
increases intracellular Ca2+
-Also found in thyroid C cells (calcitonin), kidney, and brain
Actions of Parathyroid Hormone
1. Action on bone:
2 main effects:
1. Fast Ca efflux from labile pool to plasma
2. Stimulation of bone dissolution (Long term effect)
Acts on an osteoblast cell
membrane receptor
↑ cell permeability to calcium.
The increase in cytosolic calcium
activates a pump that drives
calcium from the bone to the
ECF. The pump is enhanced by
1,25 (OH)2D3
PTH and Osteoblastogenesis
Osteoclast Mediated Bone Resorption
PTH and Kidney
Action on kidney:
1. enhances reabsorption of calcium from distal tubules.
2. reduces the uptake of phosphate in the proximal tubules of the
kidney
3. Enhances activity of 1 Hydroxylaseα → ↑ Vit D
PTHrP; Parathyroid Hormone related Protein
• shares the same N-terminal end as parathyroid hormone and it
therefore can bind to the same receptor
• plays a role in the development of hypercalcemia of malignancy
– Some lung cancers are associated with hypercalcemia
– Other cancers can be associated with hypercalcemia
• Aids in normal mammary gland development and lactation as well as
placental transfer of calcium
• May be important in fetal development
Disorders of PTH secretion
Hyperparathyroidism:
characterized by hypercalcemia, hypercalcuria, hypophosphatemia, and
hyperphosphaturia
Etiology:
1. Primary hyperparathyroidism : dysfunction in the parathyroid glands
themselves
2. Secondary hyperparathyroidism : resistance to the actions of PTH,
usually due to chronic renal failure.
3. Tertiary: rare forms caused by long lasting disorders of the calcium
feedback control system.
Primary hyperparathyroidism:
Cause: benign parathyroid adenoma
multiple endocrine neoplasia
C/F:
Complications:
osteitis fibrosa cystica, osteoporosis, osteomalacia, and arthritis.
Rx: surgical removal
Secondary hyperparathyroidism:
Cause: renal failure Vit D, phosphate↓ ↑
Insoluble calcium phosphate forms
Tertiary hyperparathyroidism:
hyperparathyroidism can not be corrected by medication
basis of treatment is still prevention in chronic renal failure
Pseudohypoparathyroidism
• Symptoms and signs
– Hypocalcemia
– Hyperphosphatemia
– Characteristic physical appearance: short stature, round face,
short thick neck, obesity, shortening of the metacarpals
• Resistance to parathyroid hormone
• The patients have normal parathyroid glands, but they fail to respond
to parathyroid hormone or PTH injections
• Symptoms begin in children of about 8 years
– Tetany and seizures
– Hypoplasia of dentin or enamel and delay or absence of eruption
occurs in 50% of people with the disorder
Pseudohypoparathyroidism
Hypoparathyroidism
Signs
Hypocalcemia : tremor, tetany and, eventually, convulsions.
Causes
Accidental surgical removal
Autoimmune invasion most common non-surgical cause. It can occur as
part of autoimmune polyendocrine syndromes.
Hemochromatosis.
Absence or dysfunction of the parathyroid glands is one of the
components of chromosome 22q11 microdeletion syndrome
Idiopathic (of unknown cause), occasionally familial
Rx: calcium and Vitamin D3 supplementation , Teriparatide
Vitamin D
Intake: average daily intake of vitamin D – 500 IU
recommended intake is 400 IU/day
(1 mg of vitamin D3 = 40 000 IU).
Vitamin D Metabolism
Vit D regulation
Actions of Vit D:
1. Intestine
Action on bone:
Action on Kidney:
1. Weakly stimulates renal Ca reabsorption
2. Stimulates transport of Ca into skeletal and cardiac muscle
Vit D deficiency
Rickets/Osteomalacia
Causes: Inadequate intake and absence of sunlight
defective mineralization of the bone matrix
A deficiency of renal 1 -hydroxylase produces renal ricketsα
Sex linked gene on the X chromosome
Renal tubular defect of phosphate resorption
Teeth may be hypoplastic and eruption may be retarded
Calcitonin
• Product of parafollicular C cells of the thyroid
• Acts to lower plasma Ca conc
• Action on bone: deactivation of osteoclast
promotion of phosphate entry into bone
• Action on kidney: Ca excretion↑
small in urinary phosphate excretion↑
Other hormones
1. GH: absorption from small intestine↑
2. Insulin: favors bone formation, imp during fetal development
3. Prolactin: favors hydroxylation of Vit D
4. Anabolic hormones: stimulate growth, act on cartilage
5. Estrogen: primarily retard bone resorption, promote positive Ca
balance, induce 1 hydroxylaseα
6. Thyroxine: Ca mobilisation osteoporosis↑ →
7. Glucocorticoids:
- ↓ Ca & Phosphate absorption in small intestine
- ↑ renal Ca excretion
- Inhibit osteoclast diffrentiation Ca levels PTH→ ↓ → ↑
Disorders of calcium &phosphate metabolism
Hypercalcemia
Hypocalcemia
hyperphosphatemia
Hypophosphatemia
Hypercalcemia
Causes:
1. primary hyperparathyroidism
2. malignancy
3. Granulomatous diseases:
- sarcoidosis, TB
4. Endocrinopathies:
- Hyperthyroidism
- Adrenal Insufficiency
5. Medications
- Thiazide diuretics
- Lithium
- Vit D
- Milk alkali syndrome
C/F
Polyurea Lethargy Impaired renal function
Polydipsia Anorexia hypertension
Renal calculi Depression ectopic calcification of
Drowsiness arterial walls, corneal
calcifications
Skeletal and radiologic changes:
-early stages demineralization & subperiosteal erosions in phalanges
- Pepper pot appeareance in lat ceph
- Nephrocalcinosis
- Soft tissue changes
- Ostetis fibrosa cystica
Management:
Initial therapy: fluids and diuretics
hydration, increasing salt intake, and forced diuresis
Additional therapy: bisphosphonates and calcitonin
Hypocalcemia
Causes:
1. Hypothyroidism
2. Hypoalbuminaria
- Idiopathic
- Surgical
- Transient, post op
- Magnesium defiency
3. Pseudohypoparathyroidism
4. Vit D disorders
Hyperphosphatemia
- Renal Insuffiency
5. Acute pancreatitis
C/F:-
Perioral tingling and parasthesia,earliest symptom of hypocalcemia.
Tetany, carpopedal spasm are seen.
latent tetany :
Trousseau sign
Chvostek's sign Tendon reflexes are depressed
life threatening complications
Laryngospasm
cardiac arrhythmias
Management
Two ampoules of intravenous calcium gluconate 10% is given slowly
in a period of 10 minutes, or if the hypocalcemia is severe, calcium
chloride is given instead.
Maintenance doses of both calcium and vitamin-D (often as 1,25-
(OH)2-D3, i.e. calcitriol)) are often necessary to prevent further
decline
Hypophosphatemia
Seen when plasma phosphate level less than 0.4 mmol/l
C/F: muscle pain & weakness
respiratory muscle weakness
cardiac arrythmias
confusion, convulsion, coma
hypercalciurea
Causes
- Vit D defiency - oral absorption (Antacids)↓
- Malabsorption - phosphate removal
- ↑ CHO metabolism & insulin Haemedialysis
Hyperphosphatemia
Causes: 1. Increased intake
Excessive parenteral administration of phosphate
Milk-alkali syndrome
Vitamin D intoxication
2. Decreased excretion
Renal failure, acute or chronic
Hypoparathyroidism
Pseudohypoparathyroidism
3. Shift of phosphate from intracellular to extracellular space
Rhabdomyolysis
Tumor lysis
Acute hemolysis
C/f:
muscle cramps, tetany
joint pain, pruritus, or rash
fatigue, shortness of breath, anorexia, nausea, vomiting, and sleep
disturbances
Management:
phosphate binders, diet restrictions, volume repletion with saline
coupled with forced diuresis
Hypophosphatasia:
Defienciency of Alk phosphatase
Types: Infantile - severe rickets, hypercalcemia, bone abnormalities,
failure to thrive
Childhood - Infections, growth retardation↑
Adult – spontaeneous #
Oral findings: premature exfoliation of teeth
Hypocalcification of teeth & large pulp chambers
Rx: Vit D – partial improvement
High doses of phosphate – 0.25-0.75 gms QID
Pathologic calcifications
Dystrophic calcification:
Not dependent on blood Ca but local conditions
Seen in fibromas, pulps, BV walls
Metastatic calcification
Occurs in undamaged tissue
↑ blood CA
Hyperparathyroidism
Hypervitaminosis D
Mainly in kidneys, lungs, gastric mucosa
Osteoporosis
Osteoporosis is characterized by a significant reduction in bone
mineral density compared with age- and sex-matched norms
There is a decrease in both bone mineral and bone matrix
Women lose 50% of their trabecular bone and 30 % of their cortical
bone
30% of all postmenapausal women will sustain an osteoporotic
fracture as will 1/6th
of all men
Normal and Osteoporotic Bone
FDA Approved Rx’s for Osteoporosis
Bisphosphonates (alendronate and risedronate)
Calcitonin,
Parathyroid hormone
Raloxifene
Teriparatide, a form of parathyroid hormone, is a newly approved
osteoporosis medication. It is the first osteoporosis medication to
increase the rate of bone formation in the bone remodeling cycle
Periodontal considerations
Plaque: Inorganic component predominantly calcium & phosphate
Calculus
Osteoporosis:
Von Vowren (1983) : attachement loss in osteoporotic women↑
Wactawski wende & colleagues (1996) : found relationship between
alveolar crestal bone height and skeletal osteopenia
Dietary Ca: Nishida et al (2000) NHANES III
Using multiple logistic regression analysis, a reln found
btwn lower levels of dietary Ca & risk for periodontal disease↑
Calcium and periodontitis Clinical effect of calcium medication
Erik Uhrbom Journal of Clinical Periodontology 1984: 11: 230-241
References
Oral physiology & biochemistry : Jenkins
Textbook of physiology : Guyton
Essentials of medical pharmacology : KD Tripathi
Net references
Ca po4 metabolism 1 parasf /dental courses

Ca po4 metabolism 1 parasf /dental courses

  • 1.
    Calcium & PhosphateMetabolism INDIAN DENTAL ACADEMY Leader in continuing Dental Education
  • 2.
  • 3.
    Sources of calcium& phophorus Calcium: Milk & milk products Eggs Meat Leafy vegetables Fruits Nuts Ragi Phosphorus Same as calcium More in cereals & pulses
  • 4.
    RDA Calcium: Adult 500-800 mg/day Inpregnancy 1500 mg/day Lactating mothers 2000 mg/day New born and Infants 360 mg/day Children 800 mg/day Phosphorus Adults 500-800 mg/day Pregnant/lactating 1200 mg/day Adolscents 1200 mg/day Infants 240 mg/day
  • 5.
    Distribution of Calcium& phosphorus Calcium: Total body calcium : 1100-1200 gms Plasma Ca levels: 9-11 mg/dl 99% Bone & teeth 1%: 0.9% soft tissue, 0.1% ECF
  • 6.
  • 7.
    Phosphorus: Total body phosphorus:500-800 mg 85% bone, 15% Liver, pancreas, brain Plasma phosphate: 2.5-4.5 mg/dl Organic form: 0.5-1 mg/dl Inorganic form: 3-4 mg/dl in adults 5-6 mg/dl in children
  • 8.
    Absorption of calcium& phosphate Calcium : 40% absorption Factors influencing absorption: 1. Influencing mucosal cells 2. Influencing solubility of calcium Factors influencing mucosal cells: 1. Vit D 2. Body calcium Stores 3. Pregnancy & growth 4. Growth hormone
  • 9.
    Factors influencing availabilityof Ca in gut 1. pH 2. Amount of dietary calcium and phosphorus 3. Phytic acid & phytates 4. Oxalates 5. Fat 6. Proteins 7. Carbohydrates 8. Bile salts
  • 10.
    Absorption of phosphate: Factorsincreasing Ca absorption also increase phosphate absorption Occurs in Duodenum Small Intestine
  • 11.
    Calcium absorption Factors favoring: 1.PTH 2. Vit D 3. High protein diet 4. Acidic pH 5. Negative Cal balance 6. Pregnancy, lactation, growth 7. Carbohydrates Factors negating: 1. Oxalates, phytates 2. Excess lipid 3. Excess phosphate 4. Corticosteroids 5. Thyroid hormone 6. Alkaline pH 7. High body stores
  • 12.
    Phosphate absorption Factors favouring: 1.Low calcium diet 2. PTH 3. Vit D 4. Growth hormone Factors negating: 1. High Ca diet 2. Vit D deficiency 3. Antacids
  • 13.
    Excretion of calcium& phosphate: 1. Faeces: most of unabsorbed calcium constitutes fecal calcium 2. Urine: under full body control maintenance of homeostasis Ca in urine decreases with increased phosphate intake High phosphate diet serum Pi PTH→ ↑ → ↑ ↓ reabsorption of Ca from kidney Plasma phosphate threshold value Urine phosphate proportional to plasma phosphate Threshold value:- 2-2.4 mg/dl
  • 14.
    Functions of calcium& phosphorus Calcium: 1. Major component of skeleton, bone & teeth 2. Cell membrane stabilization 3. Maintenance of nerve excitability & muscle contraction 4. Skeletal & smooth muscle contraction 5. Neurotransmitter release 6. Activation of enzymes 7. Secretion of hormones 8. Blood coagulation
  • 15.
    Functions of phosphorus: 1.Formn of bone, teeth- hydroxyapatite 2. Essential components: Nucleoproteins phospholipids power molecules: ATP, NADPH, GTP 3. Reguln of blood pH & urine pH 4. Intermediate in fat & carbohydrate metabolism 5. Deamination & transamination of amino acids 6. Regulation of glycolysis
  • 16.
    Regulation of Calcium,Phosphate Metabolism • Organ systems that play an import role in Ca2+ metabolism – Skeleton – GI tract – Kidney • Hormones – Parathyroid hormone (PTH) – Calcitonin (CT) – Vitamin D (1,25 dihydroxycholecalciferol) – Parathyroid hormone related protein (PTHrP)
  • 17.
  • 18.
    Parathyroid Hormone secreted bythe parathyroid glands polypeptide containing 84 amino acids. Overall effect : increase Ca conc in plasma Lowers plasma phosphate concentration Regulation of PTH Secretion: Extracellular Ca ( Ca conc <7 mg/dl) Ca2+ also regulates transcription High levels of Vit D inhibit transcription
  • 19.
    Calcium Sensing Receptor(CaSR) •Parathyroid chief cells contain a Ca2+ sensing receptor (CaSR) •There are two paradoxes -The receptor responds to decreasing concentrations of agonist -Low extracellular Ca2+ increases intracellular Ca2+ -Also found in thyroid C cells (calcitonin), kidney, and brain
  • 20.
    Actions of ParathyroidHormone 1. Action on bone: 2 main effects: 1. Fast Ca efflux from labile pool to plasma 2. Stimulation of bone dissolution (Long term effect) Acts on an osteoblast cell membrane receptor ↑ cell permeability to calcium. The increase in cytosolic calcium activates a pump that drives calcium from the bone to the ECF. The pump is enhanced by 1,25 (OH)2D3
  • 22.
  • 23.
  • 24.
    PTH and Kidney Actionon kidney: 1. enhances reabsorption of calcium from distal tubules. 2. reduces the uptake of phosphate in the proximal tubules of the kidney 3. Enhances activity of 1 Hydroxylaseα → ↑ Vit D
  • 25.
    PTHrP; Parathyroid Hormonerelated Protein • shares the same N-terminal end as parathyroid hormone and it therefore can bind to the same receptor • plays a role in the development of hypercalcemia of malignancy – Some lung cancers are associated with hypercalcemia – Other cancers can be associated with hypercalcemia • Aids in normal mammary gland development and lactation as well as placental transfer of calcium • May be important in fetal development
  • 26.
    Disorders of PTHsecretion Hyperparathyroidism: characterized by hypercalcemia, hypercalcuria, hypophosphatemia, and hyperphosphaturia Etiology: 1. Primary hyperparathyroidism : dysfunction in the parathyroid glands themselves 2. Secondary hyperparathyroidism : resistance to the actions of PTH, usually due to chronic renal failure. 3. Tertiary: rare forms caused by long lasting disorders of the calcium feedback control system.
  • 27.
    Primary hyperparathyroidism: Cause: benignparathyroid adenoma multiple endocrine neoplasia C/F: Complications: osteitis fibrosa cystica, osteoporosis, osteomalacia, and arthritis. Rx: surgical removal
  • 30.
    Secondary hyperparathyroidism: Cause: renalfailure Vit D, phosphate↓ ↑ Insoluble calcium phosphate forms Tertiary hyperparathyroidism: hyperparathyroidism can not be corrected by medication basis of treatment is still prevention in chronic renal failure
  • 31.
    Pseudohypoparathyroidism • Symptoms andsigns – Hypocalcemia – Hyperphosphatemia – Characteristic physical appearance: short stature, round face, short thick neck, obesity, shortening of the metacarpals • Resistance to parathyroid hormone • The patients have normal parathyroid glands, but they fail to respond to parathyroid hormone or PTH injections • Symptoms begin in children of about 8 years – Tetany and seizures – Hypoplasia of dentin or enamel and delay or absence of eruption occurs in 50% of people with the disorder
  • 32.
  • 33.
    Hypoparathyroidism Signs Hypocalcemia : tremor,tetany and, eventually, convulsions. Causes Accidental surgical removal Autoimmune invasion most common non-surgical cause. It can occur as part of autoimmune polyendocrine syndromes. Hemochromatosis. Absence or dysfunction of the parathyroid glands is one of the components of chromosome 22q11 microdeletion syndrome Idiopathic (of unknown cause), occasionally familial Rx: calcium and Vitamin D3 supplementation , Teriparatide
  • 34.
    Vitamin D Intake: averagedaily intake of vitamin D – 500 IU recommended intake is 400 IU/day (1 mg of vitamin D3 = 40 000 IU).
  • 35.
  • 36.
  • 37.
    Actions of VitD: 1. Intestine
  • 38.
  • 39.
    Action on Kidney: 1.Weakly stimulates renal Ca reabsorption 2. Stimulates transport of Ca into skeletal and cardiac muscle
  • 40.
    Vit D deficiency Rickets/Osteomalacia Causes:Inadequate intake and absence of sunlight defective mineralization of the bone matrix A deficiency of renal 1 -hydroxylase produces renal ricketsα Sex linked gene on the X chromosome Renal tubular defect of phosphate resorption Teeth may be hypoplastic and eruption may be retarded
  • 43.
    Calcitonin • Product ofparafollicular C cells of the thyroid • Acts to lower plasma Ca conc • Action on bone: deactivation of osteoclast promotion of phosphate entry into bone • Action on kidney: Ca excretion↑ small in urinary phosphate excretion↑
  • 44.
    Other hormones 1. GH:absorption from small intestine↑ 2. Insulin: favors bone formation, imp during fetal development 3. Prolactin: favors hydroxylation of Vit D 4. Anabolic hormones: stimulate growth, act on cartilage 5. Estrogen: primarily retard bone resorption, promote positive Ca balance, induce 1 hydroxylaseα 6. Thyroxine: Ca mobilisation osteoporosis↑ → 7. Glucocorticoids: - ↓ Ca & Phosphate absorption in small intestine - ↑ renal Ca excretion - Inhibit osteoclast diffrentiation Ca levels PTH→ ↓ → ↑
  • 45.
    Disorders of calcium&phosphate metabolism Hypercalcemia Hypocalcemia hyperphosphatemia Hypophosphatemia
  • 46.
    Hypercalcemia Causes: 1. primary hyperparathyroidism 2.malignancy 3. Granulomatous diseases: - sarcoidosis, TB 4. Endocrinopathies: - Hyperthyroidism - Adrenal Insufficiency 5. Medications - Thiazide diuretics - Lithium - Vit D - Milk alkali syndrome
  • 47.
    C/F Polyurea Lethargy Impairedrenal function Polydipsia Anorexia hypertension Renal calculi Depression ectopic calcification of Drowsiness arterial walls, corneal calcifications Skeletal and radiologic changes: -early stages demineralization & subperiosteal erosions in phalanges - Pepper pot appeareance in lat ceph - Nephrocalcinosis - Soft tissue changes - Ostetis fibrosa cystica
  • 48.
    Management: Initial therapy: fluidsand diuretics hydration, increasing salt intake, and forced diuresis Additional therapy: bisphosphonates and calcitonin
  • 49.
    Hypocalcemia Causes: 1. Hypothyroidism 2. Hypoalbuminaria -Idiopathic - Surgical - Transient, post op - Magnesium defiency 3. Pseudohypoparathyroidism 4. Vit D disorders Hyperphosphatemia - Renal Insuffiency 5. Acute pancreatitis
  • 50.
    C/F:- Perioral tingling andparasthesia,earliest symptom of hypocalcemia. Tetany, carpopedal spasm are seen. latent tetany : Trousseau sign Chvostek's sign Tendon reflexes are depressed life threatening complications Laryngospasm cardiac arrhythmias
  • 51.
    Management Two ampoules ofintravenous calcium gluconate 10% is given slowly in a period of 10 minutes, or if the hypocalcemia is severe, calcium chloride is given instead. Maintenance doses of both calcium and vitamin-D (often as 1,25- (OH)2-D3, i.e. calcitriol)) are often necessary to prevent further decline
  • 52.
    Hypophosphatemia Seen when plasmaphosphate level less than 0.4 mmol/l C/F: muscle pain & weakness respiratory muscle weakness cardiac arrythmias confusion, convulsion, coma hypercalciurea Causes - Vit D defiency - oral absorption (Antacids)↓ - Malabsorption - phosphate removal - ↑ CHO metabolism & insulin Haemedialysis
  • 53.
    Hyperphosphatemia Causes: 1. Increasedintake Excessive parenteral administration of phosphate Milk-alkali syndrome Vitamin D intoxication 2. Decreased excretion Renal failure, acute or chronic Hypoparathyroidism Pseudohypoparathyroidism 3. Shift of phosphate from intracellular to extracellular space Rhabdomyolysis Tumor lysis Acute hemolysis
  • 54.
    C/f: muscle cramps, tetany jointpain, pruritus, or rash fatigue, shortness of breath, anorexia, nausea, vomiting, and sleep disturbances Management: phosphate binders, diet restrictions, volume repletion with saline coupled with forced diuresis
  • 55.
    Hypophosphatasia: Defienciency of Alkphosphatase Types: Infantile - severe rickets, hypercalcemia, bone abnormalities, failure to thrive Childhood - Infections, growth retardation↑ Adult – spontaeneous # Oral findings: premature exfoliation of teeth Hypocalcification of teeth & large pulp chambers Rx: Vit D – partial improvement High doses of phosphate – 0.25-0.75 gms QID
  • 56.
    Pathologic calcifications Dystrophic calcification: Notdependent on blood Ca but local conditions Seen in fibromas, pulps, BV walls Metastatic calcification Occurs in undamaged tissue ↑ blood CA Hyperparathyroidism Hypervitaminosis D Mainly in kidneys, lungs, gastric mucosa
  • 57.
    Osteoporosis Osteoporosis is characterizedby a significant reduction in bone mineral density compared with age- and sex-matched norms There is a decrease in both bone mineral and bone matrix Women lose 50% of their trabecular bone and 30 % of their cortical bone 30% of all postmenapausal women will sustain an osteoporotic fracture as will 1/6th of all men
  • 58.
  • 60.
    FDA Approved Rx’sfor Osteoporosis Bisphosphonates (alendronate and risedronate) Calcitonin, Parathyroid hormone Raloxifene Teriparatide, a form of parathyroid hormone, is a newly approved osteoporosis medication. It is the first osteoporosis medication to increase the rate of bone formation in the bone remodeling cycle
  • 61.
    Periodontal considerations Plaque: Inorganiccomponent predominantly calcium & phosphate Calculus Osteoporosis: Von Vowren (1983) : attachement loss in osteoporotic women↑ Wactawski wende & colleagues (1996) : found relationship between alveolar crestal bone height and skeletal osteopenia Dietary Ca: Nishida et al (2000) NHANES III Using multiple logistic regression analysis, a reln found btwn lower levels of dietary Ca & risk for periodontal disease↑ Calcium and periodontitis Clinical effect of calcium medication Erik Uhrbom Journal of Clinical Periodontology 1984: 11: 230-241
  • 62.
    References Oral physiology &biochemistry : Jenkins Textbook of physiology : Guyton Essentials of medical pharmacology : KD Tripathi Net references